Core Viewpoint - The explosion incident at Rhine Biotech resulted in one death and several injuries, prompting the company to initiate emergency response measures and investigate the cause of the accident [3][4]. Group 1: Incident Details - On August 21, 2025, at approximately 5:40 AM, an explosion occurred in a drying workshop of Rhine Biotech, leading to one fatality, three serious injuries, and four minor injuries [3][4]. - The company reported an estimated property loss of over 2 million CNY due to the incident [3]. - The company has activated its emergency response plan and is cooperating with government authorities for rescue and investigation efforts [3]. Group 2: Company Overview - Rhine Biotech is a leading enterprise in the global plant extraction industry and the first publicly listed company in China's plant extraction sector [6]. - The company specializes in the research, production, and sales of natural health products and has received several national recognitions, including "Green Factory" and "Specialized and Innovative Small Giant" [6]. Group 3: Market Reaction - Following the incident, Rhine Biotech's stock price experienced a sharp decline, closing at 8.26 CNY per share with a market capitalization of 6.1 billion CNY [7]. - The stock showed a slight increase of 0.98% on the day of the report, with a trading volume of 241,500 shares [8].

Core Viewpoint - On August 21, 2025, a drying equipment explosion occurred at Guilin Rhein Biotechnology Co., Ltd., resulting in 1 death and multiple injuries. The company is cooperating with government authorities for emergency response and investigation [1][5]. Incident Summary - The explosion took place in a drying workshop, leading to 1 fatality, 3 serious injuries, and 4 minor injuries. The company activated its emergency response plan and formed a leadership group for on-site management [1][5]. - Initial estimates indicate property damage of approximately 2 million yuan (around 0.29 million USD) due to the incident. However, the company stated that this accident would not significantly impact its future operations [1][5]. Company Profile - Guilin Rhein Biotechnology is a leading enterprise in the global plant extraction industry and the first listed company in China's plant extraction sector. The company specializes in the research, production, and sales of natural health products [5]. Financial Performance - In the first quarter of 2025, the company reported revenue of 444 million yuan (approximately 63.5 million USD), representing a year-on-year increase of 30.21%. The net profit attributable to shareholders was 30.8 million yuan (around 4.4 million USD), up 14.95% year-on-year [6]. Stock Market Reaction - Following the incident, the company's stock price fell by 4.44%, closing at 8.18 yuan per share, with a total market capitalization of 6.1 billion yuan (approximately 861 million USD) [7][8].

一条条隧道穿越山间，一个个桥墩拔地而起……"中老铁路"自2023年正式通车运营以来，铺就了促进两 国发展的"黄金通道"，有效推动云南省"走出去"企业向"兴"发展。 优化服务，"中老铁路"搭建进出口"黄金桥梁" 近年来，云南以共建"一带一路"为引领，充分发挥地理优势和资源潜力，不断加强与东南亚国家间的经 济合作。云南税务部门聚焦税费服务提质增效，认真梳理分析"走出去"企业涉税诉求，精准施策、优化 服务，为企业高效"出海"提供助力。 在中国(云南)自由贸易试验区德宏片区沿边产业园区，2024年以来新增注册企业500余家，其中制造业 企业100余家，新能源产业也在稳步布局。园区生产的产品不仅满足了国内市场的需求，还远销到周边 国家，为企业带来丰厚的利润，带动了地方经济发展。 走进云南博瑞生物科技有限公司，自动化提取的水溶生产线和油溶生产线运转繁忙，年产上千吨的产品 不断产出，陆续出口东南亚、欧美等市场。一直以来，云南博瑞生物科技有限公司致力于研发天然健康 产品，成立了专门研发中心，配备新产品研发设备30多台。 为支持鼓励中国"智"造走出国门，确保出口企业足额享受出口退税政策红利，云南税务部门主动走向生 产一线开展宣 ...